IHM
RVNC

Iguana Healthcare Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Iguana Healthcare Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-100,000
Closed -$1.36M – 103
2016
Q2 		$1.36M Buy
+100,000
New +$1.77M 0.55% 58
2015
Q4 		– Sell
-35,000
Closed -$1.04M – 84
2015
Q3 		$1.04M Buy
+35,000
New +$1.06M 0.41% 60

Other funds holding RVNC

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NHG
NQ HCIF GP Raleigh, North Carolina $50.2M AUM 45.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iguana Healthcare Management's RVNC Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2016, closing a stake of 100,000 shares — an estimated $1.36M sold.

Iguana Healthcare Management first reported a position in RVNC in Q3 2015 and held it in 2 quarters. The position peaked at $1.36M in Q2 2016. 74 funds tracked by Wall St. Rank hold RVNC as of Q3 2016.

  • Iguana Healthcare Management reported no remaining Revance Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 100,000 Revance Therapeutics, Inc. shares in Q3 2016, an estimated $1.36M.
  • Iguana Healthcare Management first reported a position in Revance Therapeutics, Inc. in Q3 2015 and held it in 2 quarters.
  • Iguana Healthcare Management's Revance Therapeutics, Inc. position peaked at $1.36M in Q2 2016.
  • 74 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.